Back
Rate this talk
Your peers have not rated this talk yet.
14-minute watch | Talk 2 of 3

EHA: How is CAR T evolving?

Evolving trends in CAR T management

Dr Yi Lin
SYMPOSIUM
EHA

Dr Yi Lin
Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA

Dr Yi Lin of Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA, provides an overview of how the CAR T landscape will evolve in the future

Read more

Talks in this series

Dr Roddie presents at EHA (Why should CAR T be used earlier in R/R DLBCL?)
10-minute watch | Talk 1 of 3
EHA: How is CAR T evolving?
Why should CAR T be used earlier in R/R DLBCL?
Dr Roddie presents at EHA (Why should CAR T be used earlier in R/R DLBCL?)
10-minute watch
EHA: How is CAR T evolving?

Why should CAR T be used earlier in R/R DLBCL?

Dr Lin presents at EHA (Evolving trends in CAR T management)
14-minute watch | Talk 2 of 3
Evolving trends in CAR T management
Dr Yi Lin
Dr Lin presents at EHA (Evolving trends in CAR T management)
14-minute watch

Evolving trends in CAR T management

Dr Yi Lin

Dr June presents at EHA (What does the future hold for CAR T manufacturing?)
11-minute watch | Talk 3 of 3
What does the future hold for CAR T manufacturing?
Dr Carl June
Dr June presents at EHA (What does the future hold for CAR T manufacturing?)
11-minute watch

What does the future hold for CAR T manufacturing?

Dr Carl June

Dr Roddie presents at EHA (Why should CAR T be used earlier in R/R DLBCL?)
10-minute watch | Talk 1 of 3
EHA: How is CAR T evolving?
Why should CAR T be used earlier in R/R DLBCL?
Dr Roddie presents at EHA (Why should CAR T be used earlier in R/R DLBCL?)
10-minute watch
EHA: How is CAR T evolving?

Why should CAR T be used earlier in R/R DLBCL?

Dr Lin presents at EHA (Evolving trends in CAR T management)
14-minute watch | Talk 2 of 3
Evolving trends in CAR T management
Dr Yi Lin
Dr Lin presents at EHA (Evolving trends in CAR T management)
14-minute watch

Evolving trends in CAR T management

Dr Yi Lin

Dr June presents at EHA (What does the future hold for CAR T manufacturing?)
11-minute watch | Talk 3 of 3
What does the future hold for CAR T manufacturing?
Dr Carl June
Dr June presents at EHA (What does the future hold for CAR T manufacturing?)
11-minute watch

What does the future hold for CAR T manufacturing?

Dr Carl June

Interested in this topic?

Find more like this

Suggested for you

Explore suggested content tailored to your role within the CAR T-cell therapy journey

Job code: IHQ-UNB-4903 Date of preparation: October 2023
Job code: IHQ-UNB-4971 Date of preparation: October 2023

▼ This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get.

Reporting of side effects 
If you get any side effects, talk to your doctor or nurse. In Great Britain and Northern Ireland, you can also report side effects directly via the Yellow Card Scheme, Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. You can also report side effects and quality complaints to Gilead. For information now how to report a side effect in another country, click here. By reporting side effects, you can help provide more information on the safety of this medicine.